A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Phase-III Study to Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
Latest Information Update: 28 Feb 2023
At a glance
- Drugs Centella asiatica extract (Primary) ; Antibacterials
- Indications Diabetic foot ulcer
- Focus Registrational; Therapeutic Use
- Sponsors Oneness Biotech
- 31 Jan 2023 According to a Oneness Biotech media release, this trial is scheduled to be completed in 2025.
- 05 Sep 2021 Status changed from not yet recruiting to recruiting.
- 01 Sep 2021 According to a Oneness Biotech media release, this trial will be completed 2-3 years after initiation.